Olema Pharmaceuticals, Inc. - Common Stock (OLMA) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
OLMA on Nasdaq
Shares outstanding
79,883,262
Price per share
$29.19
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
90,652,838
Total reported value
$2,266,511,776
% of total 13F portfolios
0.01%
Share change
+21,299,675
Value change
+$590,665,430
Number of holders
197
Price from insider filings
$29.19
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Bain Capital Life Sciences Opportunities IV, L.P. 10% 0% $244,963,774 +$47,926,339 8,508,641 +24% Bain Capital Life Sciences Opportunities IV, L.P. 31 Dec 2025
Paradigm Biocapital Advisors LP 10% $37,443,949 7,429,355 Paradigm BioCapital Advisors LP 31 Dec 2024
JANUS HENDERSON GROUP PLC 8.4% +64% $193,186,485 +$89,949,893 6,710,194 +87% JANUS HENDERSON GROUP PLC 31 Dec 2025
FMR LLC 6.3% $125,577,309 5,023,092 FMR LLC 31 Dec 2025
Logos Global Management LP 4.7% $16,172,730 3,208,875 Logos Global Management LP 18 Mar 2025
Point72 Asset Management, L.P. 2.3% $7,781,412 1,543,931 Point72 Asset Management, L.P. 31 Mar 2025

As of 31 Dec 2025, 197 institutional investors reported holding 90,652,838 shares of Olema Pharmaceuticals, Inc. - Common Stock (OLMA). This represents 113% of the company’s total 79,883,262 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) together control 92% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Bain Capital Life Sciences Investors, LLC 11% 8,508,641 +24% 16% $212,716,025
Paradigm Biocapital Advisors LP 9.4% 7,544,172 +11% 5% $188,604,300
JANUS HENDERSON GROUP PLC 8.4% 6,710,194 +87% 0.08% $167,901,108
BlackRock, Inc. 7% 5,563,260 +18% 0% $139,081,500
BVF INC/IL 6.6% 5,295,893 0% 4.5% $132,397,325
FMR LLC 6.3% 5,023,092 +16973% 0.01% $125,577,309
VANGUARD GROUP INC 4.5% 3,561,355 +11% 0% $89,033,875
Siren, L.L.C. 4.1% 3,300,700 2.5% $82,517,500
Logos Global Management LP 4% 3,208,875 0% 5.3% $80,221,875
Cormorant Asset Management, LP 3.4% 2,750,000 3.9% $68,750,000
RA CAPITAL MANAGEMENT, L.P. 3.3% 2,600,000 0.67% $65,000,000
FRANKLIN RESOURCES INC 3.1% 2,476,665 -18% 0.02% $61,916,625
LIGHTSPEED MANAGEMENT COMPANY, L.L.C. 2.4% 1,930,894 0% 3.5% $48,272,350
STATE STREET CORP 2.4% 1,884,399 +72% 0% $47,109,975
Vestal Point Capital, LP 2.1% 1,650,000 1.5% $41,250,000
Woodline Partners LP 1.9% 1,481,930 -33% 0.14% $37,048,250
Polar Capital Holdings Plc 1.7% 1,380,450 0.16% $34,511,250
GEODE CAPITAL MANAGEMENT, LLC 1.6% 1,257,441 -1.5% 0% $31,441,734
Defilade Capital Management, L.P. 1.5% 1,234,634 0% 4.2% $30,865,850
CITADEL ADVISORS LLC 1.5% 1,200,307 -3% 0.02% $30,007,675
PRICE T ROWE ASSOCIATES INC /MD/ 1.4% 1,096,035 +3349% 0% $27,402,000
SAMLYN CAPITAL, LLC 1.3% 1,069,543 0.43% $26,738,575
JENNISON ASSOCIATES LLC 1.2% 963,997 0.01% $24,099,925
DIMENSIONAL FUND ADVISORS LP 1.2% 958,644 -9.9% 0.01% $23,966,274
KINGDON CAPITAL MANAGEMENT, L.L.C. 1.2% 953,600 +12% 3.6% $23,840,000

Institutional Holders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 90,652,838 $2,266,511,776 +$590,665,430 $25.00 197
2025 Q3 68,238,531 $668,036,044 -$3,229,086 $9.79 124
2025 Q2 70,511,948 $300,429,144 +$22,565,282 $4.26 120
2025 Q1 65,888,228 $247,927,417 -$30,654,965 $3.76 131
2024 Q4 71,278,859 $415,382,388 +$48,509,843 $5.83 154
2024 Q3 58,658,581 $700,332,942 +$12,555,131 $11.94 129
2024 Q2 57,896,539 $626,445,097 +$18,080,243 $10.82 127
2024 Q1 56,110,675 $635,162,151 +$37,635,929 $11.32 125
2023 Q4 51,618,204 $717,066,039 +$56,526,765 $14.03 113
2023 Q3 47,322,813 $584,436,985 +$135,063,720 $12.35 97
2023 Q2 36,408,086 $328,764,561 +$43,216,272 $9.03 86
2023 Q1 33,447,196 $116,103,891 +$1,469,913 $3.47 65
2022 Q4 33,334,567 $81,640,055 -$481,138 $2.45 66
2022 Q3 33,359,693 $92,063,140 -$4,143,577 $2.76 67
2022 Q2 34,202,982 $139,234,855 -$8,391,103 $4.07 70
2022 Q1 36,374,849 $155,206,361 -$17,958,891 $4.26 86
2021 Q4 38,428,075 $359,510,482 -$41,441,250 $9.36 94
2021 Q3 36,741,334 $1,012,524,920 -$19,680,898 $27.56 75
2021 Q2 37,428,321 $1,047,268,923 +$59,576,299 $27.98 68
2021 Q1 35,240,926 $1,158,274,244 -$1,710,105 $33.18 73
2020 Q4 35,073,865 $1,657,230,008 +$1,657,206,010 $48.08 56